Human medicines European public assessment report (EPAR): Lyvdelzi (previously Seladelpar Gilead), seladelpar lysine dihydrate, Revision: 3, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 3 July 2025 - 10:30

Human medicines European public assessment report (EPAR): Lyvdelzi (previously Seladelpar Gilead), seladelpar lysine dihydrate, Revision: 3, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/lyvdelzi

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters